In November 2025, Invacare International Holdings Corp., a leading manufacturer of medical equipment (e.g., wheelchairs, respiratory devices, and mobility aids), suffered a ransomware attack by the RHYSIDA group. The attackers claimed to have stolen sensitive personal data—including names, addresses, dates of birth, Social Security numbers, health insurance details, medical records, and financial information—from thousands of current/former patients and employees. The stolen data was threatened for public release on the dark web if ransom demands were unmet. The breach exposed highly confidential information, posing risks of identity theft, financial fraud, and medical privacy violations. The incident triggered legal investigations, with affected individuals urged to monitor credit reports, enroll in identity protection services, and seek compensation for damages like emotional distress, lost time, and out-of-pocket expenses.

On November 4, 2025, Invacare International Holdings Corp., a medical device manufacturer, fell victim to a RHYSIDA ransomware attack. The attackers breached the company’s systems, encrypted critical files, and exfiltrated sensitive data, including personally identifiable information (PII) and protected health information (PHI)—such as names, addresses, Social Security numbers, financial details, and health records of patients, clients, and employees. The ransomware group threatened to publicly release the stolen data within six to seven days if their demands were not met.The breach poses severe risks, including identity theft, financial fraud, and reputational damage, given the sensitive nature of the exposed data. Invacare has not yet disclosed the full scope of affected individuals or organizations but is collaborating with cybersecurity experts and law enforcement to investigate and mitigate the incident. Affected parties are advised to monitor financial accounts, watch for phishing attempts, and consider credit freezes. The company may offer credit monitoring or identity theft protection as part of its response.